» Articles » PMID: 27315068

Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis

Overview
Journal PLoS One
Date 2016 Jun 18
PMID 27315068
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Vasomotor symptoms (hot flushes and night sweats) and other symptoms, including depression, anxiety and panic attacks, are commonly experienced by menopausal women and have been associated with an unfavourable cardiovascular risk profile.

Objective: To investigate whether presence of menopausal symptoms is associated with the development of cardiovascular disease (CVD).

Methods: Five electronic databases (Medline, EMBASE and Web of Science) were search until February 17th, 2015 to identify relevant studies. Observational cohort studies or randomised intervention studies were eligible for inclusion if they followed participants prospectively (at least 1 year of follow-up), and reported relevant estimates on the association of any vasomotor symptoms, or other menopausal symptoms, with risk of CVD, coronary heart disease (CHD), or stroke in perimenopausal, menopausal, or postmenopausal women. Data were extracted by two independent reviewers using a pre-designed data collection form. Separate pooled relative risks (RRs) for age and non-established cardiovascular risk factors (e.g., education, ethnicity) adjusted data and for established cardiovascular risk factors and potential mediators-adjusted data (e.g., smoking, body mass index, and hypertension) were calculated.

Results: Out of 9,987 initially identified references, ten studies were selected, including 213,976 women with a total of 10,037 cardiovascular disease outcomes. The age and non-established cardiovascular risk factors adjusted RRs) [95% confidence intervals] for development of CHD, Stroke and CVD comparing women with and without any menopausal symptoms were 1.34 [1.13-1.58], 1.30 [0.99-1.70], 1.48 [1.21-1.80] respectively, and the corresponding RRs adjusted for cardiovascular risk factors and potential mediators were 1.18 [1.03-1.35], 1.08 [0.89-1.32], 1.29 [0.98-1.71]. However, these analyses were limited by potential unmeasured confounding and the small number of studies on this topic.

Conclusion: Presence of vasomotor symptoms and other menopausal symptoms are generally associated with an increased risk of cardiovascular disease, which is mainly explained by cardiovascular risk factors.

Citing Articles

A 2-year follow-up to a randomized controlled trial on resistance training in postmenopausal women: vasomotor symptoms, quality of life and cardiovascular risk markers.

Nilsson S, Henriksson M, Hammar M, Berin E, Lawesson S, Ward L BMC Womens Health. 2024; 24(1):511.

PMID: 39272114 PMC: 11396825. DOI: 10.1186/s12905-024-03351-1.


Migraines, vasomotor symptoms, and cardiovascular disease in the Coronary Artery Risk Development in Young Adults study.

Kim C, Schreiner P, Yin Z, Whitney R, Sidney S, Ebong I Menopause. 2024; 31(3):202-208.

PMID: 38350045 PMC: 10940187. DOI: 10.1097/GME.0000000000002311.


Psychological Health and Ischemic Heart Disease in Women: A Review of Current Evidence and Clinical Considerations across the Healthspan.

Gaffey A, Spatz E Curr Atheroscler Rep. 2024; 26(3):45-58.

PMID: 38240928 PMC: 11219074. DOI: 10.1007/s11883-023-01185-0.


Obesity and Severity of Menopausal Symptoms: a Contemporary Review.

Cao V, Clark A, Aggarwal B Curr Diab Rep. 2023; 23(12):361-370.

PMID: 37999882 DOI: 10.1007/s11892-023-01528-w.


[Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists,...].

Shlyakhto E, Sukhikh G, Serov V, Dedov I, Arutyunov G, Suchkov I Probl Endokrinol (Mosk). 2023; 69(5):115-136.

PMID: 37968959 PMC: 10680541. DOI: 10.14341/probl13394.


References
1.
Szmuilowicz E, Manson J, Rossouw J, Howard B, Margolis K, Greep N . Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause. 2011; 18(6):603-10. PMC: 3123435. DOI: 10.1097/gme.0b013e3182014849. View

2.
Whooley M, Browner W . Association between depressive symptoms and mortality in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1998; 158(19):2129-35. DOI: 10.1001/archinte.158.19.2129. View

3.
Kagitani H, Asou Y, Ishihara N, Hoshide S, Kario K . Hot flashes and blood pressure in middle-aged Japanese women. Am J Hypertens. 2013; 27(4):503-7. DOI: 10.1093/ajh/hpt125. View

4.
Mittleman M, Mostofsky E . Physical, psychological and chemical triggers of acute cardiovascular events: preventive strategies. Circulation. 2011; 124(3):346-54. PMC: 3139921. DOI: 10.1161/CIRCULATIONAHA.110.968776. View

5.
Player M, Peterson L . Anxiety disorders, hypertension, and cardiovascular risk: a review. Int J Psychiatry Med. 2012; 41(4):365-77. DOI: 10.2190/PM.41.4.f. View